Charles Schwab Investment Management Inc Emergent Bio Solutions Inc. Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,105,184 shares of EBS stock, worth $9.85 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,105,184
Previous 583,271
89.48%
Holding current value
$9.85 Million
Previous $2.83 Million
148.8%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding EBS
# of Institutions
189Shares Held
39.5MCall Options Held
197KPut Options Held
128K-
Black Rock Inc. New York, NY3.84MShares$34.2 Million0.0% of portfolio
-
Oak Hill Advisors LP New York, NY3.61MShares$32.2 Million2.74% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.58MShares$31.9 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO2.29MShares$20.4 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.85MShares$16.5 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $444M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...